TherapeuticsMD, Inc. (TXMD)
CIK 25743 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for TherapeuticsMD, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 11, 2026 | 10-Q | 0001213900-26-087768 |
| Aug 11, 2026 | 8-K | 0001213900-26-087756 |
| Aug 5, 2026 | SCHEDULE 13G/A | 0001957912-26-000027 |
| May 12, 2026 | 8-K | 0001213900-26-055070 |
| May 12, 2026 | 10-Q | 0001213900-26-055081 |
| Apr 6, 2026 | SCHEDULE 13G | 0001493152-26-015371 |
| Apr 1, 2026 | NT 10-K | 0001213900-26-037914 |
| Apr 1, 2026 | 10-K/A | 0001213900-26-037918 |
| Mar 30, 2026 | 10-K | 0001213900-26-036515 |
| Mar 30, 2026 | 8-K | 0001213900-26-036519 |
| Jan 21, 2026 | 8-K | 0001213900-26-005779 |
| Dec 29, 2025 | 4 | 0000905148-25-004488 |
| Dec 16, 2025 | 8-K | 0001213900-25-122240 |
| Nov 13, 2025 | 8-K | 0001213900-25-109479 |
| Nov 5, 2025 | 4 | 0000905148-25-003782 |
| Nov 5, 2025 | 4 | 0000905148-25-003783 |
| Nov 5, 2025 | 4 | 0000905148-25-003784 |
| Nov 5, 2025 | 4 | 0000905148-25-003785 |
| Nov 3, 2025 | ARS | 0001213900-25-105185 |
| Nov 3, 2025 | DEFA14A | 0001213900-25-105184 |
| Nov 3, 2025 | DEF 14A | 0001213900-25-105183 |
| Oct 24, 2025 | PRE 14A | 0001213900-25-102166 |
| Aug 12, 2025 | 10-Q | 0001213900-25-075003 |
| Aug 12, 2025 | 8-K | 0001213900-25-074975 |
| May 13, 2025 | 8-K | 0001213900-25-042663 |